Examples of Product Indication in a sentence
The obligations of CTI with respect to any Product Indication or formulation under this Article 5 are expressly conditioned upon the continuing absence of any adverse condition or event relating to the safety or efficacy of such Product Indication or formulation, and the obligation of CTI to develop or market such Product Indication or formulation shall be delayed or suspended so long as such condition or event exists.
Licensee will promptly notify Mirati of the occurrence of Generic Competition, which notice will specify the apply Generic Product, Indication, and Region in the Licensed Territory.
Within ten business days of receipt of such notice, ARScience Bio will provide written notice to Coya confirming whether or not rights to such Coya Additional Mono Product Indication have been granted to a Third Party pursuant to Section 2.7.1 (Third Party Interest).
Thereafter, Cxxx will have an exclusive right exercisable no later than 60 days after receipt of such written notice to notify ARScience Bio in writing of its desire to conduct Pre-Clinical Proof of Concept Activities for the Mono Product in the Third Party Additional Mono Product Indication (a “ROFR Exercise Notice”).
Thereafter, Coya will have an exclusive right exercisable no later than 60 days after receipt of such written notice to notify ARScience Bio in writing of its desire to conduct Pre-Clinical Proof of Concept Activities for the Mono Product in the Third Party Additional Mono Product Indication (a “ROFR Exercise Notice”).
Any such proposal will be by written notice to the other Party and will identify the Proposed Celera Product, the Platform Technology of the Agreement Instrument on which such Proposed Celera Product is run, the Product Indication addressed thereby, and the proposed launch date.
Secretary at Transocean Project Pipeline 4 * Dates of key milestones are indicative and subject to change Product Indication Preclin .
If a Party or its Affiliates, directly or through a Third Party, Commercializes a Product or Molecular Diagnostic Product in the Decentralized Market for the same Product Indication as any Product, such Party will pay to the other Party a royalty on the Net Sales of such Molecular Diagnostic Product sold or otherwise distributed by or for such Party or its Affiliates at the rates and for the periods specified in Appendix 2.4.
Protocol VB-201-064 VB-201 Attachment No. 3 Study Protocol CLINICAL PROTOCOL Title: A Randomized, Double-Blind, 12-Week, Placebo-Controlled Study Followed by a 12-Week Extension Phase Without Placebo to Evaluate the Efficacy and Safety of Oral VB-201 in Subjects with Mild to Moderate Ulcerative Colitis Protocol No. VB-201-064 Eudra CT No.: 0000-000000-00 Investigational VB-201 Product: Indication: Ulcerative Colitis Development Phase: 2 Sponsor: Vascular Biogenics Ltd.
Selected Pipeline Products and New Indications Product Indication Third Party/Licensor Phase Date of Last U.S. Patent(1) Expiry (1) Patents referenced are orange-book listable.